Free Trial

Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average - Should You Sell?

Northwest Biotherapeutics logo with Medical background

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.27 and traded as low as $0.18. Northwest Biotherapeutics shares last traded at $0.19, with a volume of 3,818,583 shares traded.

Northwest Biotherapeutics Stock Down 12.4 %

The stock has a 50-day simple moving average of $0.24 and a two-hundred day simple moving average of $0.27. The firm has a market cap of $296.22 million, a PE ratio of -2.66 and a beta of -0.67.

Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last released its earnings results on Monday, March 31st. The biotechnology company reported ($0.02) earnings per share for the quarter. The company had revenue of $0.23 million during the quarter.

Northwest Biotherapeutics Company Profile

(Get Free Report)

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Recommended Stories

Should You Invest $1,000 in Northwest Biotherapeutics Right Now?

Before you consider Northwest Biotherapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.

While Northwest Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines